Views

CrossRef citations to date

Altmetric

Letters to the Editor

Validation of the Burkitt Lymphoma International Prognostic Index in patients treated with two prospective chemoimmunotherapy trials in Spain

Josep-Maria Riberaa Hematology Department, ICO-Hospital Germans Trias i Pujol, Josep Carreras Leukemia Research Institute (IJC), Universitat Autònoma de Barcelona, Barcelona, SpainCorrespondence[email protected]

https://orcid.org/0000-0003-1042-6024

Olga Garcíaa Hematology Department, ICO-Hospital Germans Trias i Pujol, Josep Carreras Leukemia Research Institute (IJC), Universitat Autònoma de Barcelona, Barcelona, Spain

Buenaventura Buendía-Ureñab Hematology Department, Hospital Universitario 12 de Octubre, Madrid, Spain

Maria-José Terolc Hematology Department, Hospital Clínico, Valencia, Spain

Ana Vicentd Hematology Department, ICO-Hospital Joan XXIII, Tarragona, Spain

Ferran Vall-Lloverae Hematology Department, Hospital Mútua Terrassa, Terrassa, Spain

Juan Berguaf Hematology Department, Hospital San Pedro de Alcántara, Cáceres, Spain

https://orcid.org/0000-0001-8229-1208

Irene García-Cadenasg Hematology Department, Hospital de Sant Pau, Barcelona, Spain

Jordi Esteveh Hematology Department, Hospital Clínic, Barcelona, Spain

https://orcid.org/0000-0002-8056-648X

Jordi Riberaa Hematology Department, ICO-Hospital Germans Trias i Pujol, Josep Carreras Leukemia Research Institute (IJC), Universitat Autònoma de Barcelona, Barcelona, Spain

Evelyn Acuña-Cruzi Hematology Department, Hospital Universitario y Politécnico La Fe, Valencia, Spain

Pilar Herreraj Hematology Department, Hospital Ramón y Cajal, Madrid, Spain

Jesus-Maria Hernández-Rivask Hematology Department, Hospital Universitario de Salamanca, Salamanca, Spain

Pau Abrisquetal Hematology Department, Hospital Universitari Vall d’Hebron, Barcelona, Spain

José González-Camposm Hematology Department, Hospital Universitario Virgen del Rocío, Sevilla, Spain

https://orcid.org/0000-0002-4892-067X

Carlos Rodríguezn Hematology Department, Hospital Universitario de Gran Canaria Doctor Negrín, Las Palmas de Gran Canaria, Spain

Mariana Bastos-Oreiroo Hematology Department, Hospital Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain

Eulàlia Genescàa Hematology Department, ICO-Hospital Germans Trias i Pujol, Josep Carreras Leukemia Research Institute (IJC), Universitat Autònoma de Barcelona, Barcelona, Spain

Nerea Caminosp Hematology Department, Hospital Universitario de Donostia, San Sebastián, Spain

Maria-Paz Queipo de Llanoq Hematology Department, Hospital Universitario Virgen de la Victoria, Málaga, Spain

Antònia Claderar Hematology Department, Hospital Universitari Son Llàtzer, Palma de Mallorca, Spain

Juan-Manuel Sanchoa Hematology Department, ICO-Hospital Germans Trias i Pujol, Josep Carreras Leukemia Research Institute (IJC), Universitat Autònoma de Barcelona, Barcelona, Spain

& on behalf of the Members of PETHEMA: Josep-Maria Ribera^a, Olga García^a, Ferran Vall-Llovera^e, Juan Bergua^f, Irene García-Cadenas^g, Jordi Esteve^h, Jordi Ribera^a, Evelyn Acuña-Cruzⁱ, Jesus-Maria Hernández-Rivas, José González-Campos^m, Eulàlia Genescà^a, Maria-Paz Queipo de Llano^q, Antònia Cladera^r Members of GELTAMO: Buenaventura Buendía-Ureña^b, Maria-José Terol^c, Ana Vicent^d, Pilar Herrera^j, Pau Abrisqueta^l, Carlos Rodríguezⁿ, Mariana Bastos-Oreiro^o, Nerea Caminos^p, Juan-Manuel Sancho^a Groups show all

References

Ribrag V, Koscielny S, Bosq J, et al. Rituximab and dose-dense chemotherapy for adults with Burkitt's lymphoma: a randomised, controlled, open-label, phase 3 trial. Lancet. 2016;387(10036):2402–2411.
PubMed Web of Science ®Google Scholar
Roschewski M, Dunleavy K, Abramson JS, et al. Multicenter study of risk-adapted therapy with dose-adjusted EPOCH-R in adults with untreated Burkitt lymphoma. J Clin Oncol. 2020;38(22):2519–2529.
PubMed Web of Science ®Google Scholar
Evens AM, Danilov A, Jagadeesh D, et al. Burkitt lymphoma in the modern era: real-world outcomes and prognostication across 30 US cancer centers. Blood. 2021;137(3):374–386.
PubMed Web of Science ®Google Scholar
Olszewski AJ, Jakobsen LH, Collins GP, et al. Burkitt Lymphoma International Prognostic Index. J Clin Oncol. 2021;39(10):1129–1138.
PubMed Web of Science ®Google Scholar
Ribera JM, García O, Grande C, et al. Dose-intensive chemotherapy including rituximab in Burkitt's leukemia or lymphoma regardless of human immunodeficiency virus infection status: final results of a phase 2 study (burkimab). Cancer. 2013;119(9):1660–1668.
PubMed Web of Science ®Google Scholar
Ribera JM, García O, Cervera M, et al. Rituximab and specific therapy for patients with Burkitt's leukemia and lymphoma. Results of the BURKIMAB14 trial from the Spanish PETHEMA and GELTAMO groups in 80 patients. Blood. 2019;134(Suppl. 1):2584.
Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Validation of the Burkitt Lymphoma International Prognostic Index in patients treated with two prospective chemoimmunotherapy trials in Spain

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Validation of the Burkitt Lymphoma International Prognostic Index in patients treated with two prospective chemoimmunotherapy trials in Spain

References

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date